Passer au contenu de la page principale

Dernières mises à jour sur l’uvéite

Mon statut pour la session

Quand:
13:30, Vendredi 14 Juin 2019 (1 heure 30 minutes)
Pauses:
Pause dans la salle d’exposition   03:00 PM à 03:45 PM (45 minutes)
Thème:
Uvéite
OBJECTIFS D'APPRENTISSAGE
À la fin de la session, les participants pourront :

  • Intégrer la nouvelle recherche dans la pratique clinique
  • Appliquer les résultats des tests diagnostiques à la prise de décisions cliniques
  • Décrire les agents de suppression immunitaire optimaux pour l’inflammation oculaire
  • Reconnaître les causes rares de l’uvéite

  • RÔLES CANMEDS : Érudit, expert médical

    Sous sessions

    13:30 - 13:35 | 5 minutes
    13:35 - 13:55 | 20 minutes
    Uvéite
    13:55 - 14:03 | 8 minutes
    Uvéite

    Author Block: Saanwalshah S. Saincher, Chloe Gottlieb Author Disclosure Block: S.S. Saincher: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); The Ottawa Hospital Research Institute. Description of relationship(s); Summer Student. C. Gottlieb: None.Abstract Body:Purpose: The relationship between d...

    14:03 - 14:11 | 8 minutes
    Uvéite

    Author Block: Marie-Josée Aubin, Cristina Bostan, Mariam T. Ibrahim, Mark Bamberger, Karin M. Oliver Author Disclosure Block: M. Aubin: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); University of Ottawa Eye Institute, Gilead. Description of relationship(s); Honoraria. Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); Gilead, PeriPh...

    14:11 - 14:19 | 8 minutes
    Uvéite

    Author Block: Maryam I. T. Al-Najjar, Eric FortinAuthor Disclosure Block: M.I.T. Al-Najjar: None. E. Fortin: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); advisory boards for AbbVie. Funded grants or clinical trials; Name of for-profit or not-for-profit organization(s); grants from allergan, gilaed and abbvie.Abstract Body:

    14:19 - 14:27 | 8 minutes
    UvéiteDeuxième prix, Prix d'excellence de la SCO

    SECOND PRIZE, COS AWARDS FOR EXCELLENCE IN OPHTHALMIC RESEARCHAuthor Block: James J. Armstrong, Liu Hong, Cindy M. L. HutnikAuthor Disclosure Block: J.J. Armstrong: None. L. Hong: None. C.M.L. Hutnik: None.Abstract Body:Purpose...

    14:27 - 14:35 | 8 minutes
    Uvéite

    Author Block: Maryam I. T. Al-Najjar, Marie Josee Aubin, Cristina BostanAuthor Disclosure Block: M.I.T. Al-Najjar: None. M. Aubin: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Honoraria: University of Ottawa Eye Institute, Gilead. Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s...

    14:35 - 14:43 | 8 minutes
    Uvéite

    Author Block: Fargol Mostofian, Solin Saleh, Irfan Kherani, Chloe GottliebAuthor Disclosure Block: F. Mostofian: None. S. Saleh: None. I. Kherani: None. C. Gottlieb: None.Abstract Body:Purpose: Worldwide, Toxoplasmosis is the leading cause of posterior uveitis. Atypical presentations increase misdiagnosis and risk...

    14:43 - 14:50 | 7 minutes
    Uvéite

    Author Block: Zainab Khan, Sabrina Bergeron, Miguel Burnier, Marie-Josee AubinAuthor Disclosure Block: Z. Khan: None. S. Bergeron: None. M. Burnier: None. M. Aubin: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); University of Ottawa, Gilead. Description of relationship(s); Invited speaker, Uveitis inv...

    Dr. Zainab Khan

    Participant.e
    14:50 - 15:00 | 10 minutes

    Mon statut pour la session

    Évaluer